WEBULL
WebtradeDownload

WELLNEO SUGAR (TSE:2117) Stock Sees Profit Strength Despite Revenue Drift

Simply Wall St · 3d ago

WELLNEO SUGAR stock has been grinding higher in recent weeks with a 90 day gain of about 5%. That is a calm chart for a company that just posted another quarter of solid profitability and still trades on a modest P/E of 13.2x. The headline this season is earnings power. Q1 2027 basic earnings per share came in at ¥63.50 on revenue of ¥28,601m, feeding into trailing 12 month earnings growth of 21.1%. The market is treating this as steady progress rather than a breakout, which could set the stage for a sentiment rethink.

Like the earnings power at WELLNEO SUGAR but want more options with similar profitability and balance sheet support at this valuation range? Take a look at our curated screener of 18 high quality undervalued stocks.

Q1 2027 Earnings Summary

  • Revenue, Q1 2027 vs Q1 2026: ¥28,601m vs ¥30,154m (the change reflects a lower quarterly revenue base year on year)
  • Net Income, Q1 2027 vs Q1 2026: ¥2,079m vs ¥1,708m (up 21.7%)
  • Basic EPS, Q1 2027 vs Q1 2026: ¥63.50 vs ¥52.37 (up 21.3%)
  • Trailing 12 Month Basic EPS, Q1 2027 vs Q1 2026: ¥209.01 vs ¥172.87 (up 20.9%)

Prefer clean charts instead of scrolling through extensive earnings tables and raw figures? View WELLNEO SUGAR's earnings power and valuation in a single visual snapshot with the full company report for WELLNEO SUGAR.

TSE:2117 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
TSE:2117 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

WELLNEO SUGAR earnings reinforce steady bull story

For investors leaning positive on WELLNEO SUGAR, the latest quarter supports a steady, cash generative staple story. Revenue in Q1 2027 sat at ¥28,601m, which is slightly lower than the prior year quarter, yet net income and basic EPS both moved higher by just over 20%. That points to firmer margins or better mix. Trailing 12 month EPS of ¥209.01, also up around 21%, aligns with the idea of a resilient core sugar and wellness portfolio that can generate profitability even without top line expansion.

Bear case focuses on revenue drift and volume risk

The cautious view on WELLNEO SUGAR focuses on revenue slipping from ¥30,154m to ¥28,601m year on year while earnings improved. That pattern raises questions about how much of the profit lift comes from cost work or pricing rather than underlying demand. For a staple producer facing long term health and sugar consumption concerns, flat to softer revenue can feed worries about volume pressure. The overall picture suggests near term earnings resilience, while also highlighting that growth away from commodity sugar remains important for the story.

After revenue softening while earnings improve, and with an unstable dividend track record already flagged, review our independent risk analysis for WELLNEO SUGAR which shows 1 important warning sign

Stay Ahead With Simply Wall St

If WELLNEO SUGAR's steady earnings power and modest P/E have caught your attention, register for free with Simply Wall St and add it to a Watchlist so you can track price against fair value and wait for a setup that suits you. Once you are invested, use the Portfolio Command Center to cut through headline noise and focus on key changes to fundamentals, valuation and risk. For a broader view, tap into thousands of investor viewpoints through the Community and see how others are thinking about WELLNEO SUGAR alongside peers. By spotting potential catalysts and risks early, you can make faster, more confident decisions and stay ahead of the market.

Seeking Alternatives Beyond WELLNEO SUGAR

Fresh ideas often move first. Some stocks gain momentum quietly while the crowd is distracted and ideal entry points get caught and gone. Scan these under the radar themes and consider them for further research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.